, Singapore
426 views
Chart from STI

DBS, OCBC, and UOB post combined net interest income of $8.3b in 4Q23

4Q23 marks the 5th consecutive quarter that the combined NII of the big three was above $8b.

DBS Group Holdings (DBS), Oversea-Chinese Banking Corporation (OCBC) and United Overseas Bank (UOB) have reported a combined net interest income (NII) of $8.3b in 4Q23, data from the Straits Times Index (STI) showed.

The trio of STI banks have reported a combined NII of above $8.0b for five consecutive quarters, with 4Q23 being the fifth.

“Prior to 2Q22, the three banks had reported as many as 17 consecutive quarters of combined NII between $4.0b and $5.0b, before higher interest rates saw the combined quarterly NII increase to above $6.0b in 2Q22, above $7.0b in 3Q22, and surpassing $8.0b in 4Q22,” STI reported.

For the full year (FY23), the trio reported an NII of $33b and a non-interest income (NOII) of $15b. 

The FY23 combined NII was up 22% from FY22, whilst the combined NOII of the trio was up 18% from FY22. 
 

Follow the link s for more news on

Join Singapore Business Review community
Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!

Exclusives

Chinese fine dining finds its next course in Singapore
The city-state’s high spending power and big Chinese commune make it an ideal entry point.
Singapore’s aged care homes fall short
Their services are routinary and not personalised mainly due to resource constraints.
Healthcare
ArrowBiome develops technology to kill specific bacteria in humans
The Singapore startup focuses on the personal care market but may expand to gut health soon.
Healthcare